Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Jan 2010 18:17

RNS Number : 5208F
Skyepharma PLC
13 January 2010
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SkyePharma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

Delta adjustment

 X

3. Full name of person(s) subject to the notification obligation:

D.E. Shaw & Co., L.P. D.E. Shaw & Co. (U.K.), Ltd.

4. Full name of shareholder(s) (if different from 3.):

 N/A

5. Date of the transaction and date on which the threshold is crossed or reached:

 January 11, 2010

6. Date on which issuer notified:

 January 13, 2010

7. Threshold(s) that is/are crossed or reached:

 32%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

 

 

 

 

 

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
 
Type of financial instrument
Exercise price
Expiration date
Exercise/ Conversion period
Number of voting rights instrument refers to
% of voting rights
 
Contract for Differences ("CfD") relating to convertible bond due 2024
 
March 4, 2010
 
3,461,725
Nominal
Delta 
 
14.46%
CfD relating to convertible bond due 2025
 
December 3, 2010
 
2,058,916
Nominal
Delta
 
8.60%
CfD relating to convertible bond due 2025
 
June 3, 2010
 
 2,058,916
Nominal
Delta
 
 8.60%

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

7,579,557

 

31.66%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Each of D.E. Shaw & Co., L.P. ("DESCO LP") and D.E. Shaw & Co. (U.K.), Ltd. ("DESCO UK") is notifying solely in its capacity as a discretionary investment manager. As general partner of DESCO LP, D.E. Shaw & Co., Inc. ("DESCO Inc.") is a parent undertaking of DESCO LP and DESCO UK. By virtue of David E. Shaw's position as president and sole shareholder of DESCO, Inc., which is the general partner of DESCO LP, David E. Shaw is a parent undertaking of DESCO LP and DESCO UK.

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

Stephen Back (Compliance Department)

15. Contact telephone number:

+1 212-478-0000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDXLFFBFFLBBD
Date   Source Headline
29th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) -Vectura Group PLC
29th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
29th Apr 201611:26 amPRNForm 8.3 - Skyepharma plc
29th Apr 201611:03 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
29th Apr 201610:39 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
29th Apr 201610:14 amRNSForm 8.3 - Skyepharma PLC
29th Apr 201610:12 amRNSForm 8.3 - Skyepharma PLC Replacement
29th Apr 20169:22 amRNSForm 8.3 - Skyepharma PLC
28th Apr 20163:17 pmRNSForm 8.3 - Skyepharma Plc
28th Apr 20161:54 pmRNSForm 8.3 - Skyepharma PLC]
28th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
28th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
28th Apr 201611:17 amPRNForm 8.3 - Skyepharma plc
28th Apr 201610:35 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
28th Apr 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
28th Apr 20169:41 amRNSForm 8.3 - Skyepharma PLC
28th Apr 20169:21 amBUSForm 8.3 - Skyepharma Plc
27th Apr 20163:22 pmRNSForm 8.3 - Skyepharma PLC
27th Apr 20162:45 pmRNSForm 8.3 - Skyepharma plc
27th Apr 201612:56 pmRNSForm 8.3 - [Skyepharma plc]
27th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
27th Apr 201611:25 amPRNForm 8.3 - Skyepharma Plc
27th Apr 201610:39 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
27th Apr 201610:00 amRNSForm 8.5 (EPT/RI)
27th Apr 20167:00 amRNSHolding(s) in Company
26th Apr 20163:00 pmRNSForm 8.3 - [Skyepharma plc]
26th Apr 20162:58 pmRNSForm 8.3 - Skyepharma PLC
26th Apr 20162:00 pmRNSForm 8.3 - Skyepharma PLC
26th Apr 20161:57 pmRNSForm 8.3 - Skyepharma Plc
26th Apr 201612:52 pmRNSForm 8.3 - Vectura Group Plc
26th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) -Vectura Group PLC
26th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th Apr 201611:39 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
26th Apr 201611:26 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th Apr 20168:29 amBUSForm 8.3 - Skyepharma Plc
25th Apr 20162:50 pmRNSForm 8.3 - Skyepharma Plc
25th Apr 20162:06 pmRNSForm 8.3 - Vectura Group Plc
25th Apr 20162:05 pmRNSForm 8.3 - Skyepharma Plc
25th Apr 201612:44 pmRNSForm 8.3 - [Skyepharma plc]
25th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
25th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
25th Apr 201610:34 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
25th Apr 201610:17 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
25th Apr 20169:28 amBUSForm 8.3 - Skyepharma Plc
22nd Apr 20162:42 pmRNSForm 8.3 - Skyepharma plc
22nd Apr 20161:29 pmRNSForm 8.3 - Skyepharma PLC
22nd Apr 201610:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
22nd Apr 20169:43 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
22nd Apr 20169:39 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
22nd Apr 20169:34 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.